亚洲最大福利网站_4hu四虎永久网址_麻豆国产原创_国产成人av一区二区

GlaxoSmithKline to sell soft drink brands Lucozade and Ribena
date:Apr 25, 2013
the next few years, including six that have already been submitted for approval in lung disease, melanoma, diabetes and HIV/AIDS.

Hopes for its new drug pipeline received a boost last week when a U.S. advisory panel recommended approval of Breo for smoking-related lung damage. The Food and Drug Administration is due to decide on the drug - a follow-on to GSK's top-seller Advair - by May 12.

At 1230 GMT, GSK shares were little changed at 1,681 pence.

12/25 03:05